{"slideshow_credits": null, "snippet": "I.S.S., an influential advisory firm, recommends that investors vote down the drug maker\u2019s pursuit, but a hedge fund with a stake in Mylan supports the merger.", "abstract": null, "section_name": "Business Day", "print_page": null, "document_type": "article", "byline": {"person": [{"lastname": "de la MERCED", "rank": 1, "firstname": "Michael", "role": "reported", "organization": "", "middlename": "J."}], "original": "By MICHAEL J. de la MERCED"}, "web_url": "http://www.nytimes.com/2015/08/15/business/dealbook/mylans-bid-to-buy-perrigo-is-complicated-by-opposing-declarations.html", "lead_paragraph": "I.S.S., an influential advisory firm, recommends that investors vote down the drug maker\u2019s pursuit, but a hedge fund with a stake in Mylan supports the merger.", "headline": {"main": "Mylan\u2019s Bid to Buy Perrigo Is Complicated by Opposing Declarations"}, "_id": "55ce5eac38f0d8704fb8f234", "word_count": "687", "multimedia": [], "pub_date": "2015-08-15T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"name": "subject", "value": "Drugs (Pharmaceuticals)", "is_major": "N", "rank": "1"}, {"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "is_major": "N", "rank": "2"}, {"name": "organizations", "value": "Mylan Inc", "is_major": "N", "rank": "3"}, {"name": "organizations", "value": "Perrigo Company", "is_major": "N", "rank": "4"}, {"name": "organizations", "value": "Paulson & Co", "is_major": "N", "rank": "5"}], "blog": [], "subsection_name": "DealBook", "type_of_material": "News"}